cannabichromene has been researched along with 2,4-dinitrobenzenesulfonic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borrelli, F; Capasso, R; Cascio, M; Coppola, D; Di Marzo, V; Fasolino, I; Izzo, A; Orlando, P; Pertwee, R; Piscitelli, F; Romano, B; Vassallo, L | 1 |
1 other study(ies) available for cannabichromene and 2,4-dinitrobenzenesulfonic acid
Article | Year |
---|---|
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Blotting, Western; Cannabinoids; Chromatography, Liquid; Colitis; Down-Regulation; Immunohistochemistry; Inflammation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mass Spectrometry; Mice; Mice, Inbred ICR; Nitric Oxide; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transient Receptor Potential Channels; TRPA1 Cation Channel; Up-Regulation | 2013 |